Zhitong Zeng, Mei Yang, Zhengyu Lin, Peng Huang, Yixin Pan, Chencheng Zhang, Bomin Sun, Dianyou Li
{"title":"高、低和非对称频率丘脑底刺激对帕金森病患者言语和声音的影响:一项随机试验","authors":"Zhitong Zeng, Mei Yang, Zhengyu Lin, Peng Huang, Yixin Pan, Chencheng Zhang, Bomin Sun, Dianyou Li","doi":"10.1038/s41531-025-01090-0","DOIUrl":null,"url":null,"abstract":"<p>While bilateral high-frequency subthalamic nucleus stimulation (Bi-HFS) frequently worsens speech in Parkinson’s disease (PD), low-frequency stimulation (LFS) may alleviate gait deficits but lacks robust evidence for speech benefits. This randomized trial compared Bi-LFS (60 Hz) and Bi-HFS (130 Hz) in 33 PD patients with postural instability/gait difficulty (PIGD), and evaluated asymmetric frequency stimulation (AFS) in 20 patients. Bi-LFS significantly improved dysphonia severity index (DSI, FDR-<i>p</i> = 0.024), maximum phonation time (MPT, FDR- <i>p</i> = 0.025), and subjective speech ratings compared to Bi-HFS. Left-LFS/right-HFS (L-LFS/R-HFS) matched Bi-LFS efficacy and surpassed Bi-HFS in objective measures (FDR-p ≤ 0.021). Speech improvements correlated with motor/gait gains, independent of tremor. Findings suggest Bi-LFS mitigates speech dysfunction in PIGD-PD, with left-sided LFS potentially driving benefits, while AFS provides comparable outcomes. These data support tailored stimulation protocols to optimize speech in PD. The National Medical Research Registration and Information System of China (MR-31-23-036810).</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"10 1","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of high, low, and asymmetric frequency subthalamic stimulation on speech and voice in Parkinson’s disease: a randomized trial\",\"authors\":\"Zhitong Zeng, Mei Yang, Zhengyu Lin, Peng Huang, Yixin Pan, Chencheng Zhang, Bomin Sun, Dianyou Li\",\"doi\":\"10.1038/s41531-025-01090-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>While bilateral high-frequency subthalamic nucleus stimulation (Bi-HFS) frequently worsens speech in Parkinson’s disease (PD), low-frequency stimulation (LFS) may alleviate gait deficits but lacks robust evidence for speech benefits. This randomized trial compared Bi-LFS (60 Hz) and Bi-HFS (130 Hz) in 33 PD patients with postural instability/gait difficulty (PIGD), and evaluated asymmetric frequency stimulation (AFS) in 20 patients. Bi-LFS significantly improved dysphonia severity index (DSI, FDR-<i>p</i> = 0.024), maximum phonation time (MPT, FDR- <i>p</i> = 0.025), and subjective speech ratings compared to Bi-HFS. Left-LFS/right-HFS (L-LFS/R-HFS) matched Bi-LFS efficacy and surpassed Bi-HFS in objective measures (FDR-p ≤ 0.021). Speech improvements correlated with motor/gait gains, independent of tremor. Findings suggest Bi-LFS mitigates speech dysfunction in PIGD-PD, with left-sided LFS potentially driving benefits, while AFS provides comparable outcomes. These data support tailored stimulation protocols to optimize speech in PD. The National Medical Research Registration and Information System of China (MR-31-23-036810).</p>\",\"PeriodicalId\":19706,\"journal\":{\"name\":\"NPJ Parkinson's Disease\",\"volume\":\"10 1\",\"pages\":\"\"},\"PeriodicalIF\":8.2000,\"publicationDate\":\"2025-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Parkinson's Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41531-025-01090-0\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Parkinson's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41531-025-01090-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Effect of high, low, and asymmetric frequency subthalamic stimulation on speech and voice in Parkinson’s disease: a randomized trial
While bilateral high-frequency subthalamic nucleus stimulation (Bi-HFS) frequently worsens speech in Parkinson’s disease (PD), low-frequency stimulation (LFS) may alleviate gait deficits but lacks robust evidence for speech benefits. This randomized trial compared Bi-LFS (60 Hz) and Bi-HFS (130 Hz) in 33 PD patients with postural instability/gait difficulty (PIGD), and evaluated asymmetric frequency stimulation (AFS) in 20 patients. Bi-LFS significantly improved dysphonia severity index (DSI, FDR-p = 0.024), maximum phonation time (MPT, FDR- p = 0.025), and subjective speech ratings compared to Bi-HFS. Left-LFS/right-HFS (L-LFS/R-HFS) matched Bi-LFS efficacy and surpassed Bi-HFS in objective measures (FDR-p ≤ 0.021). Speech improvements correlated with motor/gait gains, independent of tremor. Findings suggest Bi-LFS mitigates speech dysfunction in PIGD-PD, with left-sided LFS potentially driving benefits, while AFS provides comparable outcomes. These data support tailored stimulation protocols to optimize speech in PD. The National Medical Research Registration and Information System of China (MR-31-23-036810).
期刊介绍:
npj Parkinson's Disease is a comprehensive open access journal that covers a wide range of research areas related to Parkinson's disease. It publishes original studies in basic science, translational research, and clinical investigations. The journal is dedicated to advancing our understanding of Parkinson's disease by exploring various aspects such as anatomy, etiology, genetics, cellular and molecular physiology, neurophysiology, epidemiology, and therapeutic development. By providing free and immediate access to the scientific and Parkinson's disease community, npj Parkinson's Disease promotes collaboration and knowledge sharing among researchers and healthcare professionals.